Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||
| Net Income | -11,484 | -2,431 |
| Depreciation Amortization | 33 | 39 |
| Accounts receivable | -338 | -338 |
| Other Working Capital | 615 | 912 |
| Other Operating Activity | 10,460 | 2,046 |
| Operating Cash Flow | $-714 | $228 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -219 | -1 |
| Purchase Of Investment | -11,107 | N/A |
| Sale Of Investment | 3,977 | N/A |
| Other Investing Activity | 0 | -34 |
| Investing Cash Flow | $-7,349 | $-35 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 102 | 1,500 |
| Common Stock Issued | 49,249 | N/A |
| Other Financing Activity | -12 | 0 |
| Financing Cash Flow | $49,339 | $1,500 |
| Exchange Rate Effect | -15 | -80 |
| Beginning Cash Position | 1,747 | 134 |
| End Cash Position | 43,008 | 1,747 |
| Net Cash Flow | $41,261 | $1,613 |
| Free Cash Flow | ||
| Operating Cash Flow | -714 | 228 |
| Capital Expenditure | -219 | -1 |
| Free Cash Flow | -933 | 227 |